Quanterix
The company's technology allows researchers a largely automated option for measuring a large number of Alzheimer's and neurology biomarkers in blood.
People in the News at Illumina, Beckman Coulter, Oxford Nanopore, Quanterix, Akoya, Nuclera, More
Recently posted executive and academic appointments, promotions, and departures in omics and molecular diagnostics.
People in the News at Caris Life Sciences, Bio-Rad, Quanterix, Broken String Biosciences, More
Recently posted executive and academic appointments, promotions, and departures in omics and molecular diagnostics.
Quanterix Q2 Revenues Rise 11 Percent
The company reported revenue of $34.4 million, up from $31.0 million in Q2 2023 and beating the consensus Wall Street estimate of $33.7 million.
Quanterix Q1 Revenues up 13 Percent
The company's total revenues were $32.1 million, up from $28.5 million a year ago and above the consensus Wall Street estimate of $31.6 million.
Feb 29, 2024
Quanterix Q4 Revenues up 22 Percent
Aug 8, 2023
Quanterix Q2 Revenues Rise 32 Percent
Mar 6, 2023